Please provide your email address to receive an email when new articles are posted on . American Diabetes Association 68th Scientific Sessions Initial combination therapy with sitagliptin and ...
Adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes who are not adequately controlled on metformin or sitagliptin alone or in patients already being treated with ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) approved JANUMET ® XR ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- New data were presented at the American Diabetes Association (ADA) 70 th Annual Scientific Sessions from a study comparing ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with poorly controlled type 2 diabetes assigned ...
If you have type 2 diabetes, your doctor might suggest Janumet or Janumet XR as a treatment option for you. Janumet and Janumet XR are prescription drugs that are prescribed along with exercise and a ...
SAN DIEGO — Use of metformin may offer some atherosclerosis protection for patients with type 1 diabetes but does not appear to improve glycemic control, new data suggest. The multicenter trial ...
The Department of Pharmaceuticals (DoP) has directed the National Pharmaceutical Pricing Authority (NPPA) to examine the data/information once again and to re-fix the retail price of teneligliptin 20 ...
New data presented at the American Diabetes Association 70 th Annual Scientific Sessions WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- New data were presented at the American Diabetes Association (ADA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results